*3.3.3 Patient and device selection*

The decision-making process for patient and device selection in these early stages of percutaneous approaches to treat TR prompts exhaustive clinical evaluation, specifically guided right heart catheterization and transesophageal hemodynamic and anatomical evaluation, and heart team meeting. **Figure 5** summarizes a theorical approach.

#### **Figure 5.**

*Theorical algorithm for device selection. TTVI: Transcatheter tricuspid valve implantation, AP: Anteroseptal, PS: Posteroseptal, AP: Anteroposterior.*
